Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Tempus AI, Inc. - Class A Common Stock (NQ:TEM)

60.98 +0.33 (+0.54%)
Streaming Delayed Price Updated: 4:00 PM EDT, Jul 18, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Tempus AI, Inc. - Class A Common Stock

< Previous 1 2 3 4 5 6 7 Next >
Cathie Wood's Ethereum Double-Down: Ark Bets $7.9 Million On ETH-Staking ETF Buy While Selling Coinbase At Highs
On Wednesday, Cathie Wood-led Ark Invest executed significant trades, including substantial purchases in Tempus AI Inc. (NASDAQ:TEM), NVIDIA Corp. (NASDAQ:NVDA), 3iQ Ether Stakin 
Via Benzinga
Topics Artificial Intelligence ETFs
10 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
Tempus AI Stock Is Rising Wednesday: What's Happening?
Tempus AI Inc (NASDAQ:TEM) shares are trading higher Wednesday after the company announced that it received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its ejection fraction... 
Via Benzinga
Topics Artificial Intelligence
10 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
Cathie Wood Bets Another $1 Million On Tempus AI Despite Jim Cramer's Doubts, Dumps Crypto Stocks As Bitcoin Hits Fresh New Highs
On Thursday, Cathie Wood-led Ark Invest made significant trades involving Tempus AI Inc. (NASDAQ:TEM), Coinbase Global Inc. (NASDAQ:COIN), Robinhood Markets Inc. (NASDAQ 
Via Benzinga
Topics Artificial Intelligence
Cathie Wood Vs. Jim Cramer: TV Host Says Top Ark AI Pick 'Losing Money Hand Over Fist'
An AI health care stock backed by Nancy Pelosi and Cathie Wood is drawing criticism from Jim Cramer. 
Via Benzinga
Topics Artificial Intelligence
Apple Acquisition Buzz: Its $60 Billion War Chest Is Enough To Buy Datadog And Tempus
Apple's $60 billion cash pile and a rare executive shake-up reignite speculation: will the tech giant finally go on an AI buying spree to catch up with rivals? 
Via Benzinga
Topics Artificial Intelligence
Cramer Says Tesla Dominates While Ouster Is 'Too Speculative'
Jim Cramer advises against investing in Tempus AI due to its ongoing losses and suggests Pan American as a profitable alternative. Insmed is also considered speculative while the only viable option for... 
Via Benzinga
Topics Artificial Intelligence
Cathie Wood Dumps Jack Dorsey's Block As Bitcoin Flirts With All-Time Highs, Bets $8.8 million On Tempus AI
On Wednesday, the Cathie Wood-led Ark Invest made a significant move by purchasing a substantial number of shares in Tempus AI Inc. (NASDAQ:TEM) and selling shares of Block Inc. (NYSE:XYZ). 
Via Benzinga
Topics Artificial Intelligence
Cathie Wood-Led Ark Launches Buffer ETFs For Its Flagship ARKK, Analyst Says It's Like Diet Soda — 50% Loss Protection, But There's A Catch
Cathie Wood's Ark Investment Management has filed plans to launch four new exchange-traded funds designed to offer downside protection for investors in its flagship ARK Innovation ETF (BATS: ARKK),... 
Via Benzinga
Topics ETFs
Circle Internet, Centene And Li Auto Are Among Top 10 Large Cap Losers Last Week (June 30-July 4): Are The Others In Your Portfolio?
10 worst performing large-cap stocks in holiday-shortened week, including Centene Corp, Molina Healthcare, and Circle Internet Group. 
Via Benzinga
Why Tempus AI Stock Soared 15.2% in June
Via The Motley Fool
Topics Artificial Intelligence
Cathie Wood's Ark Innovation ETF Surges on AI Bets, Led by Tesla and Roblox
Via The Motley Fool
Topics Artificial Intelligence ETFs Economy
10 Under-the-Radar Healthcare Stocks With Incredible Growth Potential
Via The Motley Fool
Topics Artificial Intelligence
Assessing Tempus AI: Insights From 8 Financial Analysts
Via Benzinga
Could Personalized Medicine Be Your Portfolio's Next Big Winner? Find Out
BofA analysts review the promise and limits of AI in precision medicine, highlighting key players like Tempus, Guardant, and Exact Sciences. 
Via Benzinga
Topics Artificial Intelligence
Quantum Volatility? Tradr's New ETFs QUBX, RGTU Are Built for It, Says Matt Markiewicz
"It's the volatility that attracts traders," Matt Markiewicz, head of Product and Capital Markets at Tradr, told Benzinga. 
Via Benzinga
Topics ETFs
Members of Congress Are Pouring Millions Into These 7 Surprising Stocks
Via The Motley Fool
TEMPUS AI INC (NASDAQ:TEM) - A High-Growth Stock Meeting Minervini's Trend Template
TEMPUS AI (NASDAQ:TEM) is a high-growth healthcare tech stock meeting Minervini's Trend Template with strong revenue growth, earnings beats, and a perfect technical rating of 10/10. 
Via Chartmill
Topics Artificial Intelligence Earnings
Oracle, AST SpaceMobile And Halliburton Are Among Top 10 Large Cap Gainers Last Week (June 9-13): Are The Others In Your Portfolio?
Top 10 large-cap stocks with biggest gains last week: INSM, CRCL, ORCL, ASTS, SAIL, VG, TEM, CASY, EQNR, HAL. Have you invested in them? 
Via Benzinga
10 Health Care Stocks With Whale Alerts In Today's Session
Via Benzinga
Cathie Wood Sharers Her Take On Chatbots And Robots Taking Human Jobs: 'We'll See More People Taking Risks'
Cathie Wood argues that AI will create more jobs than it displaces, and predicts a radical change in traditional corporations. Her thesis aligns with ARK Invest's investments in chipmakers and software... 
Via Benzinga
Topics Artificial Intelligence
Why Shares of Tempus AI Are Jumping Higher This Week
Via The Motley Fool
Topics Artificial Intelligence
Update! What Is Congress Trading So Far In 2025?
Members of Congress are trading less than usual in 2025 but haven't completely given it up; this is a look at who traded what in the first half. 
Via MarketBeat
Why Tempus AI Stock Soared 15% Today
Via The Motley Fool
Topics Artificial Intelligence Stocks
Vera Therapeutics, Applied Digital, Kymera Therapeutics And Other Big Stocks Moving Higher On Monday
Via Benzinga
Tempus AI Stock Rockets After Introduction Of Liquid Biopsy Assay For Cancer Treatment Monitoring: Retail Hopes For A 20% Rally
The company stated that the assay, currently available for research use, will be clinically available later this year. 
Via Stocktwits
Topics Artificial Intelligence
Tempus AI Stock Is Surging Today: What Investors Are Watching
Tempus AI Inc (NASDAQ:TEM) shares are moving higher Monday after the company introduced a new program to monitor immunotherapy response for patients with advanced cancer. 
Via Benzinga
Topics Artificial Intelligence
Tempus AI Stock: Buy the Dip, or Is the Short-Seller Right?
Via The Motley Fool
Topics Artificial Intelligence
Why Tempus AI Stock Plummeted This Week
Via The Motley Fool
Topics Artificial Intelligence
< Previous 1 2 3 4 5 6 7 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.